• Login
    View Item 
    •   Home
    • The Christie Research Publications Repository
    • All Christie Publications
    • View Item
    •   Home
    • The Christie Research Publications Repository
    • All Christie Publications
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Browse

    All of ChristieCommunitiesTitleAuthorsIssue DateSubmit DateSubjectsThis CollectionTitleAuthorsIssue DateSubmit DateSubjectsProfilesView

    My Account

    LoginRegister

    Local Links

    The Christie WebsiteChristie Library and Knowledge Service

    Statistics

    Display statistics

    Homologous recombination repair gene mutation characterization by liquid biopsy: a phase II trial of olaparib and abiraterone in metastatic castrate-resistant prostate cancer

    • CSV
    • RefMan
    • EndNote
    • BibTex
    • RefWorks
    Thumbnail
    Name:
    cancers-13-05830-v2.pdf
    Size:
    2.216Mb
    Format:
    PDF
    Description:
    From UNPAYWALL
    Download
    Authors
    Carr, T. H.
    Adelman, C.
    Barnicle, A.
    Kozarewa, I.
    Luke, S.
    Lai, Z.
    Hollis, S.
    Dougherty, B.
    Harrington, E. A.
    Kang, J.
    Saad, F.
    Sala, N.
    Thiery-Vuillemin, A.
    Clarke, Noel W
    Hodgson, D.
    Barrett, J. C.
    Show allShow less
    Affiliation
    AstraZeneca, Cambridge CB4 0WG, UK
    Issue Date
    2021
    
    Metadata
    Show full item record
    Citation
    Carr TH, Adelman C, Barnicle A, Kozarewa I, Luke S, Lai Z, et al. Homologous Recombination Repair Gene Mutation Characterization by Liquid Biopsy: A Phase II Trial of Olaparib and Abiraterone in Metastatic Castrate-Resistant Prostate Cancer Vol. 13, Cancers. MDPI AG; 2021. p. 5830.
    Journal
    Cancers
    URI
    http://hdl.handle.net/10541/624949
    DOI
    10.3390/cancers13225830
    PubMed ID
    34830984
    Type
    Article
    ae974a485f413a2113503eed53cd6c53
    10.3390/cancers13225830
    Scopus Count
    Collections
    All Christie Publications

    entitlement

    Related articles

    • Olaparib combined with abiraterone in patients with metastatic castration-resistant prostate cancer: a randomised, double-blind, placebo-controlled, phase 2 trial.
    • Authors: Clarke N, Wiechno P, Alekseev B, Sala N, Jones R, Kocak I, Chiuri VE, Jassem J, Fléchon A, Redfern C, Goessl C, Burgents J, Kozarski R, Hodgson D, Learoyd M, Saad F
    • Issue date: 2018 Jul
    • Olaparib plus abiraterone versus placebo plus abiraterone in metastatic castration-resistant prostate cancer (PROpel): final prespecified overall survival results of a randomised, double-blind, phase 3 trial.
    • Authors: Saad F, Clarke NW, Oya M, Shore N, Procopio G, Guedes JD, Arslan C, Mehra N, Parnis F, Brown E, Schlürmann F, Joung JY, Sugimoto M, Sartor O, Liu YZ, Poehlein C, Barker L, Del Rosario PM, Armstrong AJ
    • Issue date: 2023 Oct
    • Abiraterone and Olaparib for Metastatic Castration-Resistant Prostate Cancer.
    • Authors: Clarke NW, Armstrong AJ, Thiery-Vuillemin A, Oya M, Shore N, Loredo E, Procopio G, de Menezes J, Girotto G, Arslan C, Mehra N, Parnis F, Brown E, Schlürmann F, Joung JY, Sugimoto M, Virizuela JA, Emmenegger U, Navratil J, Buchschacher GL, Poehlein C, Harrington EA, Desai C, Kang J, Saad F
    • Issue date: 2022 Sep
    • Olaparib for Chinese metastatic castration-resistant prostate cancer: A real-world study of efficacy and gene predictive analysis.
    • Authors: Dong B, Yang B, Chen W, Du X, Fan L, Yao X, Xue W
    • Issue date: 2022 May 23
    • Tolerability of Olaparib Combined with Abiraterone in Patients with Metastatic Castration-resistant Prostate Cancer: Further Results from the Phase 3 PROpel Trial.
    • Authors: Saad F, Armstrong AJ, Oya M, Vianna K, Özgüroğlu M, Gedye C, Buchschacher GL Jr, Lee JY, Emmenegger U, Navratil J, Virizuela JA, Salazar A, Maillet D, Uemura H, Kim J, Oscroft E, Barker L, Degboe A, Clarke NW
    • Issue date: 2024 Dec
    DSpace software (copyright © 2002 - 2025)  DuraSpace
    Quick Guide | Contact Us
    Open Repository is a service operated by 
    Atmire NV
     

    Export search results

    The export option will allow you to export the current search results of the entered query to a file. Different formats are available for download. To export the items, click on the button corresponding with the preferred download format.

    By default, clicking on the export buttons will result in a download of the allowed maximum amount of items.

    To select a subset of the search results, click "Selective Export" button and make a selection of the items you want to export. The amount of items that can be exported at once is similarly restricted as the full export.

    After making a selection, click one of the export format buttons. The amount of items that will be exported is indicated in the bubble next to export format.